Suppr超能文献

新型风险评估用于评估老年患者的强化治疗方案强度。

Novel risk assessment for the intensity of conditioning regimen in older patients.

机构信息

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.

The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.

出版信息

Blood Adv. 2023 Sep 12;7(17):4738-4747. doi: 10.1182/bloodadvances.2022008706.

Abstract

Reduced-intensity conditioning (RIC) regimens have long-term outcomes that are generally comparable with those of myeloablative conditioning (MAC) because of a lower risk of nonrelapse mortality (NRM) but a higher risk of relapse. However, it is unclear how we should select the conditioning intensity in individual cases. We propose the risk assessment for the intensity of conditioning regimen in elderly patients (RICE) score. We retrospectively analyzed 6147 recipients aged 50 to 69 years using a Japanese registry database. Based on the interaction analyses, advanced age (≥60 years), hematopoietic cell transplantation-specific comorbidity index (≥2), and umbilical cord blood were used to design a scoring system to predict the difference in an individual patient's risk of NRM between MAC and RIC: the RICE score, which is the sum of the 3 factors. Zero or 1 implies low RICE score and 2 or 3, high RICE score. In multivariate analyses, RIC was significantly associated with a decreased risk of NRM in patients with a high RICE score (training cohort: hazard ratio [HR], 0.73; 95% confidence interval [CI], 0.60-0.90; P = .003; validation cohort: HR, 0.57; 95% CI, 0.43-0.77; P < .001). In contrast, we found no significant differences in NRM between MAC and RIC in patients with a low RICE score (training cohort: HR, 0.99; 95% CI, 0.85-1.15; P = .860; validation cohort: HR, 0.81; 95% CI, 0.66-1.01; P = .061). In summary, a new and simple scoring system, the RICE score, appears to be useful for personalizing the conditioning intensity and could improve transplant outcomes in older patients.

摘要

强度降低的预处理方案(RIC)的长期结果与清髓性预处理方案(MAC)的结果相当,因为非复发死亡率(NRM)的风险较低,但复发的风险较高。然而,在个体病例中如何选择预处理强度尚不清楚。我们提出了用于评估老年患者预处理强度的风险评估(RICE)评分。我们使用日本注册数据库对 6147 名年龄在 50 至 69 岁的受者进行了回顾性分析。基于交互分析,采用高龄(≥60 岁)、造血细胞移植特定合并症指数(≥2)和脐带血来设计一个评分系统,以预测 MAC 和 RIC 对个体患者 NRM 风险的差异:RICE 评分,即 3 个因素的总和。0 或 1 表示低 RICE 评分,2 或 3 表示高 RICE 评分。多变量分析显示,在高 RICE 评分患者中,RIC 与 NRM 风险降低显著相关(训练队列:危险比 [HR],0.73;95%置信区间 [CI],0.60-0.90;P=0.003;验证队列:HR,0.57;95%CI,0.43-0.77;P<0.001)。相反,在低 RICE 评分患者中,MAC 和 RIC 之间的 NRM 无显著差异(训练队列:HR,0.99;95%CI,0.85-1.15;P=0.860;验证队列:HR,0.81;95%CI,0.66-1.01;P=0.061)。总之,一种新的简单评分系统——RICE 评分,似乎对个体化预处理强度有用,并可能改善老年患者的移植结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验